Lv31
290 积分 2022-11-11 加入
Targeting EGFR degradation by autophagosome degraders
14天前
已完结
Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
29天前
已完结
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery
1个月前
已完结
Recent update on the development of EZH2 inhibitors and degraders for cancer therapy
1个月前
已完结
Abstract 3307: c-Met targeting chaperone-mediated protein degrader for therapeutic intervention in NSCLC
1个月前
已关闭
c-Met targeting chaperone-mediated protein degrader for therapeutic intervention in NSCLC
1个月前
已关闭
Aurora A degradation by HSP90 interactome-mediating PROTACs in A549 and paclitaxel-resistant A549 cells
1个月前
已完结
An updated patent review of BRD4 degraders
2个月前
已完结
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
1年前
已完结
Structure Based Design of PARP Inhibitors
1年前
已完结
皖公网安备34019202002308
